The Pharmaceutical Journal
Vol 274 No 7332 p43
15 January 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Topical HIV vaccine

DermaVir, a topical DNA-containing HIV vaccine, has been shown to control virus replication and boost immune response in monkeys infected with the virus. The study is due to be published in the Journal of Investigative Dermatology.